Polpharma announced "The Best Polish Enterprise"

Polpharma has received the Business Award of the President of the Republic of Poland in the category: “The Best Polish Enterprise”.

The Business Award of the President of the Republic of Poland was presented to those companies that make a particular contribution to the business development of our country, popularise positive models and methods of achieving success in a free-market economy as well as promote and build the prestige of the Polish economy. The award was conferred in seven categories and the procedure of selecting prize winners was divided into three stages. In the first stage, authorised institutions and organisations submitted their candidates, while in the second stage, entities nominated by the Award Committee were selected. Finally, in the the third stage, laureates were chosen by the President of the Republic of Poland. Polpharma and the other award-winning companies were selected from among 170 nominated enterprises.

“The Business Award of the President of the Republic of Poland is a very prestigious distinction for Polpharma. During the more than three years after privatisation we have been able to create a strong and competitive enterprise. Currently, we are the of the Polish pharmaceuticals market. This distinction is both a milestone for us for the future and as well as motivation for intensified effort aimed at achieving the leader’s position on foreign markets as well, and especially in Central and Eastern Europe,” said Jacek Glinka, President of the Polpharma's Management Board.

“I am glad that Polish companies can combine good tradition with modernity. Achievement of such excellent economic results in a very demanding pharmaceutical industry is a huge success for both the company’s Management Board and for all its employees, even more so given that the competition on the pharmaceutical products market is very tough. Polpharma’s distinction , in my opinion, affirms the Polish pharmaceutical industry’s good standing as a very important sector of the national economy,” wrote Marek Belka, President of the Council of Ministers, in his letter addressed to Polpharma.